The crux of the UGDP. Spurious results and biologically inappropriate data analysis.
D002318:Cardiovascular Diseases / Q000401:mortality; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000628:therapy*; D003927:Diet, Diabetic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D010349:Patient Compliance; D010352:Patient Dropouts; D010629:Phenformin / Q000627:therapeutic use; D010919:Placebos; D012737:Sex Factors; D014044:Tolbutamide / Q000627:therapeutic use
D007328:Insulin; D010919:Placebos; D014044:Tolbutamide; D010629:Phenformin